Investor Frequently Asked Questions

Q.	Where is Neuralstem’s stock traded?
A.	Neuralstem’s shares are traded on the NYSE Amex Stock Exchange under the symbol "CUR" since August 2007.

Q.	When did the company go public?
A.	Neuralstem went public in December 2006.

Q.	Where are Neuralstem‘s headquarters located?
A.	Neuralstem, Inc. 9700 Great Seneca Highway Rockville, MD 20850 Phone: 301-366-4841

Q.	How many employees does Neuralstem have?
A.	As of March 13, 2009, we had 8 full-time employees. Of these employees 4 work on Research and development and 4 in administration. We also use the services of numerous outside consultants in business and scientific matters.

Q.	When do Neuralstem’s fiscal quarters end?
A.	First Quarter: March 31 Second Quarter: June 30 Third Quarter: September 30 Fourth Quarter: December 31

Q.	Who is Neuralstem’s independent auditor?
A.	Stegman & Company 405 East Joppa Road Baltimore, MD 21286

Q.	How can I buy Neuralstem stock?
A.	You may purchase CUR stock through a registered stockbroker.

Q.	Does Neuralstem have a direct stock purchase plan?
A.	No. Shares can be purchased through a registered or discount stock brokerage firm.

Q.	Whom should I contact with questions about my stock ownership?
A.	Beneficial shareholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters. If you are a registered shareholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Neuralstem’s transfer agent.

Q.	Who is Neuralstem’s transfer agent?
A.	American Stock Transfer & Trust Co. 59 Maiden Lane Plaza Level New York, NY 10038 Phone: (800) 937-5449

Q.	Where can I find financial information about Neuralstem?
A.	Neuralstem files periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on our SEC Filings page, or at www.sec.gov. In addition, Neuralstem posts recent financial information in the form of quarterly earnings press releases here on the Press Releases page.

Q.	How can I sign up to receive Neuralstem 's press releases and other company information?
A.	Click here to be added to Neuralstem’s distribution list.

Q.	Whom should I contact if I have more questions about investing in Neuralstem?
A.	Neuralstem, Inc. 301-366-4960 x1 investor@neuralstem.com

Q.	Who is Neuralstem’s PR contact?
A.	Deanne Eagle Planet Communications Phone: 917-837-5866 deanneeagle@gmail.com